NCT01697384View on ClinicalTrials.gov

Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

April 30, 2000

Primary Completion Date

August 31, 2003

Study Completion Date

October 31, 2004

Conditions
Prostate CancerAdenocarcinoma of the Prostate
Interventions
DRUG

histrelin acetate

52 week implant

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY